Treatment of Severe Diabetes Mellitus by Insulin Infusion

Kidson, Warren; Casey, John; Kraegen, Edward; Lazarus, Leslie
June 1974
British Medical Journal;6/29/1974, Vol. 2 Issue 5921, p691
Academic Journal
No abstract available.


Related Articles

  • News from the 65th ADA San Diego, US June 2005.  // PharmacoEconomics & Outcomes News;7/2/2005, Issue 481, p8 

    Presents the results of several studies on the cost of various diabetes mellitus treatments. Effect of pregablin treatment on diabetic neurophaties; Clinical benefits of insulin aspart and human insulin among patients with type 1 diabetes mellitus; Comparison of the healthcare costs of insulin...

  • Managing Type-I Diabetes in Athletes. Merrick, Mark A. // Athletic Therapy Today;Sep2001, Vol. 6 Issue 5, p40 

    Determines the occurrence of diabetes mellitus in athletes in the U.S. Infusion of subcutaneous insulin; Adjustment of insulin therapy; Difficulties for diabetic athletes in performing the event.

  • Patient preferences and randomised clinical trials . Brewin, C.R.; Bradley, C. // BMJ: British Medical Journal (International Edition);7/29/89, Vol. 298 Issue 6694, p313 

    Focuses on the use random allocation in patient treatment. Types of patient participative interventions; Difference between explanatory and pragmatic trials; Importance of insulin infusion in treating patients with diabetes mellitus.

  • Insulin Aspart: A Review of its Use in the Management of Type 1 and 2 Diabetes Mellitus. Chapman, Therese M.; Noble, Stuart; Goa, Karen L. // Drugs;2002, Vol. 62 Issue 13, p1945 

    Insulin aspart, a rapid-acting human insulin analogue, provides more rapid absorption than regular human insulin after subcutaneous administration. In most randomised, nonblind clinical trials in patients with type 1 diabetes mellitus, insulin aspart administered immediately before meals...

  • MANAGEMENT OF DIABETES.  // Current Medical Literature: Diabetes;2005, Vol. 22 Issue 4, p94 

    The article presents several studies on diabetes management. The first study examined the indications and efficacy of continuous subcutaneous insulin infusion therapy in type 1 diabetes mellitus. The second study observed the link between lower plasma triglycerides and the increased need for...

  • Insulin aspart.  // Reactions Weekly;10/22/2011, Issue 1374, p20 

    The article describes the case of a 48-year-old man with type 1 diabetes mellitus (T1DM) who developed severe insulin resistance and subsequent diabetic ketosis during treatment with insulin aspart.

  • Preliminary evaluation of intravenous infusion and intrapancreatic injection of human umbilical cord blood-derived mesenchymal stem cells for the treatment of diabetic mice. Ngoc Kim Phan; Thuy Thanh Duong; Truc Le-Buu Pham; Loan Thi-Tung Dang; Anh Nguyen-Tu Bui; Vuong Minh Pham; Nhat Chau Truong; Phuc Van Pham // Biomedical Research & Therapy;2014, Vol. 1 Issue 3, p98 

    Type 1 diabetes mellitus is characterized by the destruction of pancreatic islet beta cells, which leads to insulin insufficiency, hyperglycemia, and reduced metabolic glucose level. Insulin replacement is the current standard therapy for type 1 diabetes mellitus but has several limitations....

  • Insulin detemir is an effective long-acting human insulin analogue for the treatment of type 1 and 2 diabetes mellitus. Adis International Limited // Drugs & Therapy Perspectives;Sep2005, Vol. 21 Issue 9, p1 

    Examines the effectiveness of insulin detemir for the treatment of diabetes mellitus. Aim of insulin therapy; Effect of insulin detemir on bodyweight; Side effects of insulin detemir.

  • Insulin in the treatment of type 2 diabetes mellitus. White Jr., John R.; Campbell, R. Keith // American Journal of Health-System Pharmacy;6/1/2003, Vol. 60 Issue 11, p1145 

    Focuses on the use of insulin in the treatment of type 2 diabetes mellitus. Misconception about insulin use; Increase of cardiovascular risk.

  • Insulin receptor antibodies causing steroid responsive diabetes mellitus in a patient with myositis. Fonseca, V.; Khokher, M.A.; Dandona, P. // British Medical Journal (Clinical Research Edition);5/26/1984, Vol. 288 Issue 6430, p1578 

    Investigates the effect of insulin receptor antibodies in a patient with myositis. Treatment with steroids improving glucose tolerance; Factors important in the pathogenesis of diabetes mellitus; Cause of severe insulin resistance.


Read the Article

Other Topics